T. Rowe Price Dividend Growth Fund Advisor Class TADGX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 87.54  /  +0.14 %
  • Total Assets 22.3B
  • Adj. Expense Ratio
    0.890%
  • Expense Ratio 0.880%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Blend
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.66%
  • Turnover 10%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0

Morningstar’s Analysis TADGX

Will TADGX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Comanager Addition on T. Rowe Price Dividend Growth; Ratings Unchanged.

null Stephen Welch

Stephen Welch

Analyst Note

Associate manager David Rowlett will become a comanager of T. Rowe Price Dividend Growth alongside longtime lead manager Tom Huber on Sept. 30, 2026. Rowlett joined Huber at the beginning of the year as an associate manager. This is a sensible move for succession planning as Huber is late in his career. Rowlett continues to help with idea generation, financial analysis, and client responsibilities. He has worked at the firm for more than 17 years and currently manages T. Rowe Price US Impact Equity. Accordingly, the strategy’s High People rating and Morningstar Medalist Rating are unaffected.

Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TADGX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 30.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Apple Inc

5.71 1B
Technology

Microsoft Corp

5.24 1B
Technology

Broadcom Inc

3.49 809M
Technology

JPMorgan Chase & Co

3.33 771M
Financial Services

Visa Inc Class A

3.10 719M
Financial Services

Bank of America Corp

2.08 481M
Financial Services

GE Aerospace

1.98 458M
Industrials

ExxonMobil Holdings Corp

1.91 443M
Energy

Chubb Ltd

1.91 442M
Financial Services

Eli Lilly and Co

1.86 431M
Healthcare

Sponsor Center